CLINICAL_TRIALS
trial_result
· 2018-11-21
Clinical Trial Update: mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms [Phase 2]
Summary
Phase 2 clinical trial investigating hyperbaric oxygen therapy for persistent post-concussive symptoms after mild traumatic brain injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Traumatic Brain Injury With Brief Loss of Consciousness, Post-Concussion Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-11-21